finanzen.net

Axsome Therapeutics Aktie WKN: A2AA7B / ISIN: US05464T1043
Symbol: AXSM

13,12EUR
+1,89EUR
+16,83%
15:33:15
15,19USD
+2,19USD
+16,85%
17:45:39
KAUFEN
VERKAUFEN
mehr Daten anzeigen

Axsome Therapeutics News

10.01.19
Is This Why Axsome Therapeutics Is Losing Ground Again Today? (MotleyFool)
08.01.19
Here's Why Axsome Therapeutics Has Been a Rocket Ship This Week (MotleyFool)
08.01.19
Axsome Therapeutics extends gains after raising $23.3M to fund late stage depression drug development (Proactiveinvestors)
07.01.19
Axsome Therapeutics Inc soars after unveiling rosy trial results for depression drug (Proactiveinvestors)
07.01.19
Axsome Therapeutics soars after unveiling rosy trial results for depression drug (Proactiveinvestors)
07.01.19
Axsome Therapeutics, Inc. : Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder (Investegate)
10.12.18
UPDATE: Axsome Therapeutics shares soar 24% premarket on positive trial of Alzheimer's therapy (Market Watch)
22.05.18
Axsome Therapeutics to Present at the 2018 BIO International Convention (Globe Newswire)
08.05.18
BRIEF-Axsome Therapeutics Reports Q1 Loss Per Share Of $0.19 (Reuters Business)
08.05.18
Axsome Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update (Globe Newswire)
26.04.18
Axsome Therapeutics Announces Positive Outcome of Interim Analysis of STRIDE-1 Phase 3 Trial of AXS-05 in Treatment Resistant Depression (Globe Newswire)
23.04.18
BRIEF-Axsome Therapeutics Announces First Patient Enrolled In Phase 2 Clinical Trial Of AXS-05 In Smoking Cessation (Reuters Business)
23.04.18
Axsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking Cessation (Globe Newswire)
19.04.18
BRIEF-Axsome Therapeutics Appoints Nick Pizzie, Cpa, Mba, As Chief Financial Officer (Reuters Business)
27.03.18
Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence (Globe Newswire)
26.03.18
Axsome Therapeutics to Present at H.C. Wainwright Annual Global Life Sciences Conference (Globe Newswire)
19.03.18
Axsome Therapeutics to Present at 17th Annual Needham Healthcare Conference (Globe Newswire)
12.03.18
Axsome Therapeutics Presents Scientific Rationale for the Development of AXS-05 at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (Globe Newswire)
07.03.18
Axsome Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update (Benzinga)
07.03.18
Axsome Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update (Globe Newswire)
28.02.18
Axsome Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018 (Globe Newswire)
26.02.18
Axsome Therapeutics Announces Primary Endpoint Met in Phase 1 Trial of Next Generation Product Candidate AXS-09 Containing Chirally Pure Esbupropion and Dextromethorphan (Globe Newswire)
05.02.18
Axsome Therapeutics to Present at 2018 BIO CEO & Investor Conference (Globe Newswire)
09.01.18
Axsome Therapeutics Announces AXS-02 Independent Data Monitoring Committee Recommends Continuation of COAST-1 Trial and Discontinuation of CREATE-1 Trial (Globe Newswire)
19.12.17
Axsome Therapeutics to Present at Biotech Showcase 2018 (Globe Newswire)
06.12.17
Axsome Therapeutics Announces Closing of $9.5 Million Registered Direct Offering (Globe Newswire)
01.12.17
Axsome Therapeutics Announces $9.5 Million Registered Direct Offering Priced At-the-Market (Globe Newswire)
28.11.17
Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine (Globe Newswire)
08.11.17
Axsome Therapeutics Reports Third Quarter 2017 Financial Results (Globe Newswire)
08.11.17
Axsome Therapeutics Reports Third Quarter 2017 Financial Results (Benzinga)
09.08.17
Axsome Therapeutics Reports Second Quarter 2017 Financial Results (Benzinga)
09.05.17
Axsome Therapeutics Reports First Quarter 2017 Financial Results (Benzinga)
07.03.17
Axsome Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update (Benzinga)

Axsome Therapeutics News

Axsome Therapeutics News: auf dieser Seite finden Sie alle Axsome Therapeutics News und Nachrichten zur Axsome Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Axsome Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Axsome Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Meistgelesene Axsome Therapeutics News

Keine Nachrichten gefunden.

Axsome Therapeutics Peer Group News

Keine Nachrichten gefunden.
finanzen.net Brokerage

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
BayerBAY001
Deutsche Bank AG514000
Daimler AG710000
Apple Inc.865985
CommerzbankCBK100
Aurora Cannabis IncA12GS7
Amazon906866
Deutsche Telekom AG555750
BASFBASF11
Allianz840400
E.ON SEENAG99
TeslaA1CX3T
Volkswagen (VW) AG Vz.766403
SteinhoffA14XB9